Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Thermo Fisher, Luminex, DuPont, Others Win US Patents

Premium

Life Technologies (Thermo Fisher Scientific) has been awarded US Patent No. 8,845,984, "Apparatus for and method of processing biological samples."

Joseph Amshey, Daniel Bezdek, Espir Kahatt, Alexander Khorlin, Lance Parsons, Todd Peterson, Timothy Powers, Michael Thacker, Timothy Updyke, and Kornelija Zgonc are named as inventors.


Stanford has been awarded US Patent No. 8,846,314, "Isotachophoretic focusing of nucleic acids."

Robert Chambers, Juan Santiago, Alexandre Persat, Reto Schoch, and Mostafa Ronaghi are named as inventors.


Luminex has been awarded US Patent No. 8,846,317, "Systems and methods for multiplex analysis of PCR in real time."

Douglas Whitman and Charles Collins are named as inventors.


Panasonic has been awarded US Patent No. 8,846,318, "Method for identifying olfactory receptor included in one olfactory cell."

Masato Suzuki is named as the inventor.


Clondiag has been awarded US Patent No. 8,846,313, "Assays."

Katrin Steinmetzer, Eugen Ermantraut, Torsten Schulz, Thomas Kaiser, and Thomas Ullrich are named as inventors.


DuPont has been awarded US Patent No. 8,846,349, "Sequences and their use for detection and characterization of E. coli O157:H7."

Frank Burns is named as the inventor.


Focus Diagnostics has been awarded US Patent No. 8,846,391, "Methods and compositions for detecting herpes simplex virus type 2."

Xin Su, Lilly Kong, and Wayne Hogrefe are named as inventors.


Intelligent BioSystems has been awarded US Patent No. 8,846,581, "Non-emulsion methods and masked biomolecules."

Steven Gordon and Daniel Stetson are named as inventors.


Pacific Biosciences has been awarded US Patent No. 8,846,881, "Modular nucleotide compositions and uses therefor."

Jonas Korlach and Jeffrey Wegener are named as inventors.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.